Paragon 28, Inc. (NYSE:FNA – Get Free Report) major shareholder Mvm Partners, Llc sold 619,747 shares of the firm’s stock in a transaction on Tuesday, March 4th. The shares were sold at an average price of $12.99, for a total value of $8,050,513.53. Following the sale, the insider now directly owns 9,609,771 shares of the company’s stock, valued at $124,830,925.29. This represents a 6.06 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Mvm Partners, Llc also recently made the following trade(s):
- On Thursday, March 6th, Mvm Partners, Llc sold 164,664 shares of Paragon 28 stock. The shares were sold at an average price of $13.01, for a total value of $2,142,278.64.
- On Monday, January 27th, Mvm Partners, Llc sold 27,142 shares of Paragon 28 stock. The shares were sold at an average price of $11.62, for a total value of $315,390.04.
- On Thursday, January 23rd, Mvm Partners, Llc sold 20,136 shares of Paragon 28 stock. The shares were sold at an average price of $11.63, for a total value of $234,181.68.
Paragon 28 Stock Performance
FNA stock opened at $13.03 on Friday. The business’s 50-day moving average price is $12.07 and its two-hundred day moving average price is $9.33. The company has a current ratio of 3.50, a quick ratio of 1.60 and a debt-to-equity ratio of 0.79. The firm has a market cap of $1.09 billion, a PE ratio of -17.60 and a beta of 1.54. Paragon 28, Inc. has a 1-year low of $4.65 and a 1-year high of $13.13.
Institutional Inflows and Outflows
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on FNA. William Blair lowered Paragon 28 from an “outperform” rating to a “market perform” rating in a research report on Wednesday, January 29th. Stephens restated an “equal weight” rating and issued a $13.00 price target (down from $14.00) on shares of Paragon 28 in a research report on Thursday, January 30th. Canaccord Genuity Group set a $13.00 price target on Paragon 28 in a research report on Wednesday, January 29th. Finally, Needham & Company LLC restated a “hold” rating and issued a $13.00 price target on shares of Paragon 28 in a research report on Wednesday, January 29th. Four investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average target price of $14.20.
Get Our Latest Research Report on Paragon 28
About Paragon 28
Paragon 28, Inc develops, distributes, and sells foot and ankle surgical systems in the United States and internationally. It offers plating systems, including gorilla plating systems, such as lisfranc, lapidus, lateral column, calcaneus slide, and naviculocuneiform (NC) fusion plating systems; baby gorilla plate-specific screws, navicular fracture plates, and 5th metatarsal hook plates; and silverback plating systems.
Read More
- Five stocks we like better than Paragon 28
- What is an Earnings Surprise?
- Is Myers Industries Poised for a Breakout?
- About the Markup Calculator
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- Ride Out The Recession With These Dividend KingsĀ
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for Paragon 28 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Paragon 28 and related companies with MarketBeat.com's FREE daily email newsletter.